Compare VEON & TIVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VEON | TIVC |
|---|---|---|
| Founded | 1992 | 2016 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.3M |
| IPO Year | 1996 | 2021 |
| Metric | VEON | TIVC |
|---|---|---|
| Price | $52.60 | $1.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $73.25 | N/A |
| AVG Volume (30 Days) | 82.1K | ★ 2.5M |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 8.91 | N/A |
| Revenue | ★ $4,226,000,000.00 | $482,000.00 |
| Revenue This Year | $10.29 | N/A |
| Revenue Next Year | $7.27 | N/A |
| P/E Ratio | $5.92 | ★ N/A |
| Revenue Growth | ★ 6.74 | N/A |
| 52 Week Low | $34.55 | $1.47 |
| 52 Week High | $64.00 | $15.64 |
| Indicator | VEON | TIVC |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 37.94 |
| Support Level | $52.04 | $1.51 |
| Resistance Level | $54.41 | $2.51 |
| Average True Range (ATR) | 1.29 | 0.27 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 69.93 | 8.40 |
VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.